Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
In this section, we usually try to help investors determine whether Evergrande Health Industry Group is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Evergrande Health Industry Group has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.
Show me the analysis anyway
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
Evergrande Health Industry Group. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
Evergrande Health Industry Group's
is considered below, and whether this is a fair price.
Price based on past earnings
Evergrande Health Industry Group's earnings available for a low price, and how does
this compare to other companies in the same industry?
Evergrande Health Industry Group has negative assets, we can't compare the value of its assets to the HK Healthcare industry average.
Take a look at our analysis of 708’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Evergrande Health Industry Group's regulatory filings and announcements.
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Evergrande Health Industry Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Healthcare industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Evergrande Health Industry Group
expected to grow at an
Unable to compare Evergrande Health Industry Group's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare Evergrande Health Industry Group's earnings growth to the Hong Kong market average as no estimate data is available.
Unable to compare Evergrande Health Industry Group's revenue growth to the Hong Kong market average as no estimate data is available.
Unable to determine if Evergrande Health Industry Group is high growth as no earnings estimate data is available.
Unable to determine if Evergrande Health Industry Group is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
Evergrande Health Industry Group's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
Evergrande Health Industry Group
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
A company's financial position is much like your own financial position,
it includes everything you own
The boxes below represent the relative size of what makes up
Evergrande Health Industry Group's finances.
The net worth of a company is the difference between its assets and liabilities.
Evergrande Health Industry Group is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Evergrande Health Industry Group's cash and other short term assets cover its long term commitments.
This treemap shows a more detailed breakdown of
Evergrande Health Industry Group's finances. If any of them are yellow this
indicates they may be out of proportion and red means they relate to one of the
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
High level of physical assets or inventory.
Evergrande Health Industry Group has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Nearly all companies have debt. Debt in itself isn’t
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.
The graphic below shows equity (available funds) and debt, we ideally want to
see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and
whether the level has increased over the past 5 years.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Mr. Siquan Li is the Chief Executive Officer Health Industry Group Limited since July 20, 2018 and also served as it's executive Director since July 20, 2018 Until February 1,2019. He tapped into the real estate industry and has over 12 years of experience in various areas such as investment, development and marketing. He graduated from Hohai University with a bachelor’s degree in engineering management and studied at the department of construction management, Tsinghua University for a master’s degree in project management. Prior to joining the Company, Mr. Li was the general manager of China Evergrande Group Hainan Company and the vice president of Evergrande Ocean Flower Island Industry Group. In 2017, he was appointed as the executive vice president of Evergrande Tourism Group and the chairman of Suzhou Evergrande Fairyland Company.
Insufficient data for Siquan to compare compensation growth.
Siquan's remuneration is about average for companies of similar size in Hong Kong.
Management Team Tenure
Average tenure and age of the
Evergrande Health Industry Group
management team in years:
The average tenure for the Evergrande Health Industry Group management team is less than 2 years, this suggests a new team.
Chief Executive Officer
Chief Financial Officer
Chief Editor of Weekend Weekly
Suet Chung Tso
Publisher and Chief Editor of Oriental Sunday
Chief Editor of Fashion & Beauty
Chi Ming Cheung
Chief Editor of New Monday and Publisher of Fashion & Beauty
Chief Editor of Economic Digest
Board of Directors Tenure
Average tenure and age of the
Evergrande Health Industry Group
board of directors in years:
The average tenure for the Evergrande Health Industry Group board of directors is less than 3 years, this suggests a new board.
Why You Should Like Evergrande Health Industry Group Limited’s (HKG:708) ROCE
Specifically, we're going to calculate its Return On Capital Employed (ROCE), in the hopes of getting some insight into the business. … Understanding Return On Capital Employed (ROCE). … ROCE measures the amount of pre-tax profits a company can generate from the capital employed in its business.
Should We Be Delighted With Evergrande Health Industry Group Limited's (HKG:708) ROE Of 43%?
To keep the lesson grounded in practicality, we'll use ROE to better understand Evergrande Health Industry Group Limited (HKG:708). … Evergrande Health Industry Group has a ROE of 43%, based on the last twelve months. … Check out our latest analysis for Evergrande Health Industry Group?
Evergrande Health Industry Group Limited (HKG:708) Earns A Nice Return On Capital Employed
To be precise, we'll consider its Return On Capital Employed (ROCE), as that will inform our view of the quality of the business. … Return On Capital Employed (ROCE): What is it? … ROCE measures the amount of pre-tax profits a company can generate from the capital employed in its business.
Is Evergrande Health Industry Group Limited's (HKG:708) 43% Better Than Average?
We'll use ROE to examine Evergrande Health Industry Group Limited (HKG:708), by way of a worked example. … Over the last twelve months Evergrande Health Industry Group has recorded a ROE of 43%. … See our latest analysis for Evergrande Health Industry Group?
What Should You Know About Evergrande Health Industry Group Limited's (HKG:708) Return On Capital?
and want to begin learning the link between Evergrande Health Industry Group Limited (HKG:708)’s return fundamentals and stock market performance. … Purchasing Evergrande Health Industry Group gives you an ownership stake in the company. … Thus, to understand how your money can grow by investing in Evergrande Health Industry Group, you need to look at what the company returns to owners for the use of their capital, which can be done in many ways but today we will use return on capital employed (ROCE)
Evergrande Health Industry Group Limited (HKG:708) Delivered A Better ROE Than The Industry, Here’s Why
and want to better understand how you can grow your money by investing in Evergrande Health Industry Group Limited (HKG:708). … Evergrande Health Industry Group Limited (HKG:708) delivered an ROE of 36.64% over the past 12 months, which is an impressive feat relative to its industry average of 8.18% during the same period. … Sustainability can be gauged by a company’s financial leverage – the more debt it has, the higher ROE is pumped up in the short term, at the expense of long term interest payment burden
Is Evergrande Health Industry Group Limited's (HKG:708) 36.64% ROE Strong Compared To Its Industry?
View our latest analysis for Evergrande Health Industry Group Breaking down ROE — the mother of all ratios Return on Equity (ROE) is a measure of Evergrande Health Industry Group’s profit relative to its shareholders’ equity. … Return on Equity = Net Profit ÷ Shareholders Equity ROE is measured against cost of equity in order to determine the efficiency of Evergrande Health Industry Group’s equity capital deployed. … Evergrande Health Industry Group’s ROE is impressive relative to the industry average and also covers its cost of equity.
How Financially Strong Is Evergrande Health Industry Group Limited (HKG:708)?
Small-caps and large-caps are wildly popular among investors, however, mid-cap stocks, such as Evergrande Health Industry Group Limited (SEHK:708), with a market capitalization of HK$27.30B, rarely draw their attention from the investing community. … View our latest analysis for Evergrande Health Industry Group Does 708 generate an acceptable amount of cash through operations? … I recommend you continue to research Evergrande Health Industry Group to get a more holistic view of the stock by looking at: Historical Performance: What has 708's returns been like over the past?
Who Owns Most Of Evergrande Health Industry Group Limited (HKG:708)?
In this article, I'm going to take a look at Evergrande Health Industry Group Limited’s (SEHK:708) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject among investors. … SEHK:708 Insider_trading Feb 20th 18 General Public Ownership The general public holds a substantial 24.92% stake in 708, making it a highly popular stock among retail investors. … Thus, investors should dig deeper into 708's business relations with these companies and how it can affect shareholder returns in the long-term.Next Steps: With a low level of institutional ownership, investors in 708 need not worry about non-fundamental factors such as ownership structure causing large impact on stock prices.
What You Must Know About Evergrande Health Industry Group Limited's (HKG:708) Risks
If you are looking to invest in Evergrande Health Industry Group Limited’s (SEHK:708), or currently own the stock, then you need to understand its beta in order to understand how it can affect the risk of your portfolio. … Check out our latest analysis for Evergrande Health Industry Group An interpretation of 708's beta Evergrande Health Industry Group’s five-year beta of 2.47 means that the company’s value will swing up by more than the market during prosperous times, but also drop down by more in times of downturns. … However, this is the opposite to what 708’s actual beta value suggests, which is higher stock volatility relative to the market.
Evergrande Health Industry Group Limited, an investment holding company, operates as a health management company in the People’s Republic of China. It develops and sells health and living properties; and provides community health management, medical cosmetology, and anti-aging services, as well as elderly care and rehabilitation. The company is involved in the wholesale of home care and healthcare products; and cosmetic products, as well as provision of healthcare services, hospital management, and software and advertisement design services. In addition, it offers information technology consultancy services. The company engages in the real estate development and operations; research and development of pharmaceuticals; and production of medical equipment. Further, it is involved in the research, development, production, and sales of new energy vehicles. The company was formerly known as New Media Group Holdings Limited and changed its name to Evergrande Health Industry Group Limited in April 2015. Evergrande Health Industry Group Limited was founded in 1999 and is headquartered in Guangzhou, China. Evergrande Health Industry Group Limited is a subsidiary of China Evergrande Group.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.